Tedco awards $600K to tech firms - bizjournals:

vypybiza.wordpress.com
The money was granted in collaboratio n withthe U.S. Army Medicap Research and Materiel Command and the throughthe Ft. Detricik Technology Transfer Initiative. The purpose of the technologh transfer program is to raise awareness of new and developingf technologies and funding them to transitiobn as viable projectsfor follow-on fundinbg in the market place. Each company that received funding was awardedapproximatelyy $50,000 between March 2008 and May making up the initiative’s second rounrd of financial awards since its $750,0000 program extension. The funds for the program’s second phased were secured by Sen. Barbara Mikulski, D-Md., and Rep. Roscoe G. R-Md. “The [Ft.
Detrick Technology Transfeer Initiative] program is enabling area businesses to harnessa the technologies being developed at Fort Detrick and apply them to thecommercial sector,” said Mikulski. “This will lead to new products that have the powef to create jobs and save Mikulski announced the first phased of the tech transfer program in Marchj 2005 when 11 companiesreceived funding. in The company is developing a health care technolog y calledmiTag system, which is a scalable wireless sensor solution for improving patienf flow. in Frederick: The company is developing a technolog y called the GeNova Screennto identify, isolate, and produce antibody-like molecules.
in Rockville: The company is developingy an on-demand biotech products including a combination vaccin against plagueand anthrax. BioAssayy Works LLC in Ijamsville: The compan is developing a lateral-flow visual diagnostic test to detecgt and differentiate single sample multiplrpathogenic poxviruses, including variola, vaccinia, and in Catonsville: The company is safety-testing a medical producft called ClotFoam, which is a intracavitary hemostatic agent. CynerGene IDMP in The companyis developing, validating and implementingf a supplemental diagnosis of Malaria, HIV, and Dengus using its Infectious Disease Multiplex Panel approach, which could allos for creation of biosensors.
LLC in Baltimore: The companyg is developing required components and system framework to enable conversationa l interfaces fortelemedicine tools. Such tools would allowe professional medics touse gesture, and other human-- computer interactions to access and document information in electronic medical in Rockville: The company is developinb technology to preserve mammalian cells in driedx format that can easily be re-hydrated for a variety of LLC in Frederick: The company is evaluating the effec of Imagilin patented probiotics as a food supplement to enhanc the immune responsiveness of guinea pigs upon immunizatiohn or challenge with virulent pathogens.
The evaluation will suggest the ability of Imagilin patented probiotics to enhance the immunization of a in Baltimore: The company is developin micropatterned substrates for viral infectivity assays. Juxtopia in The company is customizing its Wearablew Assistance and Situational Awareness goggles and service toallow U.S. Army combat medics to access and document information to electricao medical recordsvia hands-free voice-requests and in Baltimore: The company is developing cell therapiess to treat brain and spinak cord injuries.